Video Shorts

Precision Strategies and Targeted Combinations in GU Oncology From ESMO 2025

Breaking Down the Surgical Management of Known Metastatic Cancer

The Multidisciplinary Use of Radiation, Systemic Therapy, and Surgery in Oncology

Examining the Role of Taxpayer-Funded Clinical Trials in Cancer Care

Unpacking the Phase 3 KEYNOTE-905/EV-303 Trial

The Role of AI for Oncology Insurance Prior Authorization Processes

The Evolving CLL Treatment Paradigm

The Importance of Increasing Global Access to Biomarker Testing in Lung Cancer

Benefits and Limitations of MRI in Soft Tissue Sarcoma Surveillance

Experts Align on Priorities in Lung Cancer Care At Global BTG Lung 2025

The Evolution of Surgical Oncology

The Reality of Missed Genetic Testing

What to Know About the FDA Approval of BVd in Multiple Myeloma

Go Behind-the-Scenes With OncLive at ESMO 2025

Can AI Insights Unlock Broader Access to NGS and Targeted Therapy?

Global Voices, Shared Vision: Aligning Clinical Priorities in Lung Cancer

The FDA Approval of SIR-Spheres Y-90 Resin Microspheres for Unresectable HCC

Previewing the Phase 2 NorthStar Trial Ahead of the 2025 ESMO Congress

The FDA Approval of Adjuvant Cemiplimab for High-Rish Cutaneous Squamous Cell Carcinoma

The Complexities of Cancer Care in the Elderly

Key Takeaways From MiBA 2025: The Future of AI in Oncology

How Real-World Studies Address Gaps in Randomized Clinical Trial Data in mCRC

Updates in Primary Brain Tumor Management

Decision Support in Oncology

Making the Case for PFS Over OS in Clinical Trials

The Association Between HIV Status and Age at Presentation in Multiple Myeloma

The Role of Subcutaneous On-Body Delivery Systems in Myeloma Management

The Push to Bring ctDNA to Clinical Practice for CRC

2025 MiBA Community Summit: Behind the Scenes

First Annual International Brain Tumor Symposium: Experts Recap the Latest Advances in Brain Cancer